Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.

Puumalainen T, Dagan R, Wuorimaa T, Zeta-Capeding R, Lucero M, Ollgren J, Käyhty H, Nohynek H.

Pediatr Infect Dis J. 2003 Feb;22(2):141-9.

PMID:
12586978
3.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609.

PMID:
19325450
4.
5.

The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.

Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S89-96. doi: 10.1097/INF.0b013e318199f901.

PMID:
19325451
6.

Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants.

Puumalainen T, Zeta-Capeding MR, Käyhty H, Lucero MG, Auranen K, Leroy O, Nohynek H.

Pediatr Infect Dis J. 2002 Apr;21(4):309-14.

PMID:
12075762
7.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
8.
9.

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR.

Pediatr Infect Dis J. 2001 Oct;20(10):931-40.

PMID:
11642626
10.

Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.

Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.

J Am Geriatr Soc. 2004 Nov;52(11):1883-7.

PMID:
15507066
11.

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults.

Powers DC, Anderson EL, Lottenbach K, Mink CM.

J Infect Dis. 1996 Apr;173(4):1014-8.

PMID:
8603942
12.

Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine.

Wuorimaa T, Käyhty H, Eskola J, Bloigu A, Leroy O, Surcel HM.

Scand J Immunol. 2001 Apr;53(4):422-8.

13.

Immunological responses to pneumococcal vaccine in frail older people.

Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB.

Vaccine. 2009 Mar 4;27(10):1628-36. doi: 10.1016/j.vaccine.2008.11.098. Epub 2008 Dec 17. Erratum in: Vaccine. 2009 Nov 5;27(47):6649.

PMID:
19100304
14.

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF.

Vaccine. 2001 Nov 12;20(3-4):545-53.

PMID:
11672921
15.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.

Zangwill KM, Greenberg DP, Chiu CY, Mendelman P, Wong VK, Chang SJ, Partridge S, Ward JI.

Vaccine. 2003 May 16;21(17-18):1894-900.

PMID:
12706674
16.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
17.

Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine.

Obaro SK, Enwere GC, Deloria M, Jaffar S, Goldblatt D, Brainsby K, Hallander H, McInnes P, Greenwood BM, McAdam KP.

Pediatr Infect Dis J. 2002 Oct;21(10):940-7.

PMID:
12394817
18.

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC, Starkovich PT, Dunstan M, Carste B, Shay DK, Baggs J, Carlone GM.

Vaccine. 2007 May 16;25(20):4029-37. Epub 2007 Mar 12.

PMID:
17391816
19.

Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides.

Musher DM, Groover JE, Watson DA, Pandey JP, Rodriguez-Barradas MC, Baughn RE, Pollack MS, Graviss EA, de Andrade M, Amos CI.

J Investig Med. 1997 Feb;45(2):57-68.

PMID:
9084576
20.

Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.

Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R.

Vaccine. 2000 Nov 22;19(7-8):886-94.

PMID:
11115712

Supplemental Content

Support Center